Connection

Michael Ostrowski to Carrier Proteins

This is a "connection" page, showing publications Michael Ostrowski has written about Carrier Proteins.
Connection Strength

0.934
  1. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol Cell Biol. 2007 Jun; 27(11):4018-27.
    View in: PubMed
    Score: 0.224
  2. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res. 2004 Aug; 19(8):1339-48.
    View in: PubMed
    Score: 0.182
  3. Ets-2 interacts with co-repressor BS69 to repress target gene expression. Anticancer Res. 2003 May-Jun; 23(3A):2173-8.
    View in: PubMed
    Score: 0.171
  4. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem. 2002 Mar 29; 277(13):11077-83.
    View in: PubMed
    Score: 0.156
  5. Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Res. 2018 11; 28(11):1090-1102.
    View in: PubMed
    Score: 0.125
  6. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science. 2009 Aug 28; 325(5944):1142-6.
    View in: PubMed
    Score: 0.066
  7. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem. 2003 Jun 27; 278(26):24209-16.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.